Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating two doses of a distal jejunal-release dextrose bead formulation combined with a gel versus placebo in obese adults with w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Distal Jejunal-release Dextrose Beads with Gel (distal jejunal-release dextrose beads with gel formulation)

Snippet

Sponsor: Aphaia Pharma US LLC | Conditions: Obese With Comorbidities, Obese Patients (BMI ≥ 30 kg/m²) | Phase 2 | Status: RECRUITING